RxDoctor Payments Data

Reggie Parlier, MD

Family Medicine · Gastonia, NCNPI 1285617399

Payments from drug & device makers

$3,089in general payments, 2019–2025

Across 182 payments — averaging $16.97 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$647
  • Pfizer$370
  • Novo Nordisk$301
  • Amgen$291
  • GSK$234
  • Astellas Pharma US Inc$204
  • plus $1K from 22 others

What the payments were for

  • Food & beverage$2,96496%
  • Education$1254%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$3,089 in reported general payments places this provider in the 80th percentile of 3,444 family medicine providers in North Carolina.

See all family medicine providers in North Carolina

Medicare billing

Part B allowed, 2024
$55,678
Medicare patients
76
Services billed
845

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban44$64,671
Trelegy ElliptaFluticasone/Umeclidin/Vilanter26$39,059
JardianceEmpagliflozin27$34,859
OzempicSemaglutide25$28,197
Combivent RespimatIpratropium/Albuterol Sulfate15$24,553
FarxigaDapagliflozin Propanediol23$19,553
JanuviaSitagliptin Phosphate11$13,766
MyrbetriqMirabegron14$12,254
JanumetSitagliptin Phos/Metformin Hcl21$11,374
Lantus SolostarInsulin Glargine,hum.Rec.Anlog55$8,909
Novolog FlexpenInsulin Aspart19$3,940
Humalog Kwikpen U-100Insulin Lispro13$3,120
Atorvastatin Calcium336$3,004
Metoprolol Succinate180$2,765
SynthroidLevothyroxine Sodium30$2,302

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis$370$64,67144 claims
Boehringer IngelheimJardiance, Combivent Respimat$40$59,41242 claims
GSKTrelegy Ellipta$234$39,05926 claims
Novo NordiskOzempic$301$28,19725 claims
MerckJanuvia, Janumet$42$25,14032 claims
AstraZenecaFarxiga$71$19,55323 claims
Astellas Pharma US IncMyrbetriq$204$12,25414 claims
AbbVieSynthroid$647$2,30230 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 3,444 family medicine providers in North Carolina.

Other family medicine in Gastonia

See the full list for North Carolina

Where these figures come from

Is this you, or does something look wrong? →